Infect Chemother. 2013 Jun;45(2):175-83. doi: 10.3947/ic.2013.45.2.175. Epub 2013 Jun 26.

Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea.

Infection & chemotherapy

Jieun Kim, Mi-Ran Seo, Jung Oak Kang, Tae Yeal Choi, Hyunjoo Pai

PMID: 24265965 PMCID: PMC3780953 DOI: 10.3947/ic.2013.45.2.175

Abstract

BACKGROUND: Binary toxin-producing Clostridium difficile infections (CDI) are known to be more severe and to cause higher case fatality rates than those by binary toxin-negative isolates. There has been few data of binary toxin-producing CDI in Korea. Objective of the study is to characterize clinical and microbiological trait of CDI cause by binary-toxin producing isolates in Korea.

MATERIALS AND METHODS: From September 2008 through January 2010, clinical characteristics, medication history and treatment outcome of all the CDI patients were collected prospectively. Toxin characterization, PCR ribotyping and antibiotic susceptibility were performed with the stool isolates of C. difficile.

RESULTS: During the period, CDI caused by 11binary toxin-producing isolates and 105 toxin A & toxin B-positive binary toxin-negative isolates were identified. Comparing the disease severity and clinical findings between two groups, leukocytosis and mucoid stool were more frequently observed in patients with binary toxin-positive isolates (OR: 5.2, 95% CI: 1.1 to 25.4, P = 0.043; OR: 7.6, 95% CI: 1.6 to 35.6, P = 0.010, respectively), but clinical outcome of 2 groups did not show any difference. For the risk factors for acquisition of binary toxin-positive isolates, previous use of glycopeptides was the significant risk factor (OR: 6.2, 95% CI: 1.4 to 28.6, P = 0.019), but use of probiotics worked as an inhibitory factor (OR: 0.1, 95% CI: 0.0 to 0.8; P = 0.026). PCR ribotypes of binary toxinproducing C. difficile showed variable patterns: ribotype 130, 4 isolates; 027, 3 isolates; 267 and 122, 1 each isolate and unidentified C1, 2 isolates. All 11 binary toxin-positive isolates were highly susceptible to clindamycin, moxifloxacin, metronidazole, vancomycin and piperacillin-tazobactam, however, 1 of 11 of the isolates was resistant to rifaximin.

CONCLUSIONS: Binary toxin-producing C. difficile infection was not common in Korea and those isolates showed diverse PCR ribotypes with high susceptibility to antimicrobial agents. Glycopeptide use was a risk factor for CDI by those isolates.

Keywords: Binary toxin; Clinical characteristics; Clostridium difficile; PCR ribotype; Susceptibility

References

1. Korean J Lab Med. 2010 Oct;30(5):491-7 - PubMed
2. Dis Colon Rectum. 1995 Apr;38(4):350-4 - PubMed
3. J Korean Med Sci. 2009 Jun;24(3):520-4 - PubMed
4. Clin Infect Dis. 2008 Jan 15;46 Suppl 1:S32-42 - PubMed
5. Emerg Infect Dis. 2009 May;15(5):761-5 - PubMed
6. J Med Microbiol. 2005 Feb;54(Pt 2):181-185 - PubMed
7. Lancet. 2005 Sep 24-30;366(9491):1079-84 - PubMed
8. Am J Surg. 1995 May;169(5):480-3 - PubMed
9. Int J Antimicrob Agents. 2012 Jul;40(1):24-9 - PubMed
10. N Engl J Med. 2005 Dec 8;353(23):2433-41 - PubMed
11. Thorac Surg Clin. 2007 Aug;17(3):343-51 - PubMed
12. Korean J Lab Med. 2011 Jul;31(3):191-6 - PubMed
13. Clin Microbiol Infect. 2013 Jun;19(6):521-7 - PubMed
14. Anaerobe. 2009 Dec;15(6):230-3 - PubMed
15. N Engl J Med. 2008 Oct 30;359(18):1932-40 - PubMed
16. J Infect Dis. 2006 Apr 15;193(8):1143-50 - PubMed
17. Annu Rev Microbiol. 2011;65:501-21 - PubMed
18. J Clin Microbiol. 2000 Jun;38(6):2386-8 - PubMed
19. Infect Control Hosp Epidemiol. 2007 Feb;28(2):131-9 - PubMed
20. J Korean Med Sci. 2011 Oct;26(10):1258-64 - PubMed
21. Lancet. 2011 Jan 1;377(9759):63-73 - PubMed
22. Clin Infect Dis. 2007 Aug 1;45(3):302-7 - PubMed
23. Clin Infect Dis. 2007 Jan 15;44(2):238-44 - PubMed
24. PLoS Pathog. 2009 Oct;5(10):e1000626 - PubMed
25. Emerg Infect Dis. 2011 Jun;17(6):976-82 - PubMed
26. Clin Infect Dis. 2012 Dec;55(12):1661-8 - PubMed

Show all 26 references

Publication Types

• Journal Article